BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto Study

Erstveröffentlichung

2018

Authors

Fasching, Peter A.

Loibl, Sibylle

Hu, Chunling

Hart, Steven N.

Shimelis, Hermela

et al.

Wissenschaftlicher Artikel

Published in

Journal of Clinical Oncology ; 36 (2018), 22. - S. 2281+. - ISSN 0732-183X. - eISSN 1527-7755

Link to publication

https://dx.doi.org/10.1200/JCO.2017.77.2285

Institutions

UKU. Comprehensive Cancer Center Ulm (CCCU)

Subject headings

[DDC subject group]: DDC 610 / Medicine & health

---

Metadata

Show full item record